RIGEL ONE CARE
LIVE

Serial Number

87817100

Owner

Rigel Pharmaceuticals, Inc.

Attorney

Jamed J. Saul

Filing Date

Mar 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

RIGEL ONE CARE Trademark

Serial Number: 87817100 • Registration: 6102551

RIGEL ONE CARE is a trademark filed by Rigel Pharmaceuticals, Inc. on March 1, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Rigel Pharmaceuticals, Inc. (27 trademarks)

772 Lucerne Drive
Sunnyvale, CA 94086

Entity Type: 03

Trademark Details

Filing Date

March 1, 2018

Registration Date

July 14, 2020

Published for Opposition

September 17, 2019

Goods & Services

Medical information services; Medical informational services, namely, providing information regarding prescription drugs for drug distributors, insurance companies, pharmacies and medical professionals; Providing a website featuring information for medical professionals, pharmacies, insurance companies and drug distributors regarding therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, and medical information about the administration and dosing of pharmaceuticals; Patient support services relating to treatment of medical disorders, namely, providing information relating to therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information, namely, providing resources in the field of pharmaceuticals for treatment of diseases and links to such resources; Medical information services, namely, providing a website in the medical, pharmaceutical and health fields featuring information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and/or drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of patient treatment and treatment protocols

Advisory services and consultancy regarding healthcare benefits and pharmacy benefits; providing information and guidance in connection with health, medical, and pharmacy insurance benefit plans; insurance consultation services, namely, assisting physician offices and patients to identify the scope of coverage offered by patient medical and pharmaceutical insurance; insurance consultation services, namely, assisting physician offices and patients to obtain prior authorization for medical and pharmaceutical insurance claims and the preparation and submission of related paperwork and assisting physician offices and patients to appeal denial of medical and pharmaceutical insurance claims and the preparation and submission of related paperwork; Financial information, namely, providing reimbursement information, drug pricing, payment tracking, and co-payment information to health care providers, insurers and consumers; Financial administration of health reimbursement arrangements, namely, providing an internet website portal featuring financial information to healthcare professionals, patients and patient caregivers relating to reimbursement for pharmaceutical preparations, health care and prescription drugs

Providing a database for collecting and reporting information pertaining to medical treatment, insurance, and prescription drug dispensing and management for business purposes; Business administration of a patient support program, which helps patients, in coordination with their healthcare provider, access, start, and comply with therapy as prescribed, and provides co-pay assistance, assistance with insurance and healthcare providers, coverage and reimbursement information, general education and support, and information about products, health topics, and related resources; Providing business information and billing services in the field of healthcare, namely, providing reimbursement information, drug pricing, payment tracking, co-payment data and other market intelligence to health care providers, insurers and consumers; Providing consumer product information relating to prescription drugs to distributors, pharmacies and consumers; Distribution of product advertising materials for sales representatives of prescription drugs; Assisting patients in enrolling in pharmaceutical reimbursement programs of others; Providing a website featuring information for medical professionals, pharmacies, insurance companies and drug distributors regarding retail pharmacy business information about the administration and dosing of pharmaceuticals; Medical billing support services, namely, providing an internet website portal featuring billing information to healthcare professionals, patients and patient caregivers relating to reimbursement for pharmaceutical preparations, health care and prescription drugs

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 14, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 14, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 12, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 8, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 14, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 25, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 12, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 11, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 19, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 19, 2020 AITU
USE AMENDMENT FILED
May 4, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
May 4, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2019 NONP
ASSIGNED TO LIE
Aug 9, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 29, 2019 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2019 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 29, 2019 GNFN
FINAL REFUSAL E-MAILED
Jan 29, 2019 GNFR
FINAL REFUSAL WRITTEN
Jan 29, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2018 NWOS
NEW APPLICATION ENTERED
Mar 5, 2018 NWAP